Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ARWR | Common Stock | Purchase | $27.5K | +1K | +3.26% | $27.49 | 31.7K | Mar 18, 2024 | Direct | F1 |
transaction | ARWR | Common Stock | Purchase | $28K | +1K | +3.16% | $28.00 | 32.7K | Mar 19, 2024 | Direct | |
transaction | ARWR | Common Stock | Purchase | $27.5K | +1K | +3.06% | $27.50 | 33.7K | Mar 20, 2024 | Direct |
Id | Content |
---|---|
F1 | The price reported on Column 4 is the weighted average price. These shares were purchase in multiple transactions at prices ranging from $ 27.48 to $ 27.50, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4. |